Riad Sherif reports a stock award at Ocular Therapeutix
By AlphaYouPublished Form 4
Sherif Riad
Reporting filer
Riad Sherif reports a stock award, not an open-market purchase or sale, in Ocular Therapeutix, Inc. Form 4 filed Nov 10, 2026 lists 2 entries.
- Disclosed
- Nov 10, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sherif Riad | 2026-11-06 | A | Grant or award | 28000 | 0 | 28,000 | 4 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Sherif Riad | 2026-11-06 | A | Grant or award | 88000 | 0 | 88,000 | 4 days | Filed terms
|
Common Stock
- Owner
- Sherif Riad
- Date
- 2026-11-06
- Code
- A
- Action
- Grant or award
- Quantity
- 28000
- Price
- 0
- Following holdings
- 28,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-06
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 28000
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 28000
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Sherif Riad
- Date
- 2026-11-06
- Code
- A
- Action
- Grant or award
- Quantity
- 88000
- Price
- 0
- Following holdings
- 88,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 6.60
- transaction Date: 2026-11-06
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 88000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-11-05
- underlying Security Title: Common Stock
- underlying Security Shares: 88000
- shares Owned Following Transaction: 88000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sherif Riad: Director.
- F1: On November 6, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest over three years, vesting 1/3 on each yearly anniversary of the date of grant.
- F2: Subject to the reporting person's continued service on the Company's board of directors, the options will vest over three years, vesting 1/3 on each yearly anniversary of the date of grant.
Original sources
Prepared automatically from public filing data. Report a correction.